Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
Leuprorelin Combined With Letrozole With/Without Everolimus in Ovarian-Suppressed Premenopausal Women With Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: The LEO StudyEur. J. Cancer 2021 Feb 01;144(xx)341-350, JH Jeong, JE Kim, JH Ahn, KH Jung, SJ Koh, J Cheon, J Sohn, GM Kim, KS Lee, SH Sim, IH Park, SB Kim
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.